Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2697 |
|
Actual shortage: | 241 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2447 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2023-06-08 | 2023-06-21 | 194094 |
TEVA-NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2023-07-04 | 2023-07-14 | 197052 |
TEVA-NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2023-10-05 | 2023-12-14 | 206392 |
TEVA-NAPROXEN EC | 375MG | TABLET (ENTERIC-COATED) | Resolved | 2024-01-11 | 2024-03-18 | 215719 |
TEVA-QUETIAPINE XR | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-13 | 2017-10-10 | 1748 |
TEVA-QUETIAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-13 | 2017-10-11 | 1760 |
TEVA-QUETIAPINE XR | 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-13 | 2018-02-21 | 1769 |
TEVA-QUETIAPINE XR | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-13 | 2017-10-10 | 1778 |
ACT OXYCODONE CR | 5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-17 | 2017-09-19 | 3366 |
ACT OXYCODONE CR | 10MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-17 | 2017-09-19 | 3377 |
ACT OXYCODONE CR | 20MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-17 | 2017-07-01 | 3381 |
ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-17 | 2017-09-19 | 3384 |
TEVA-QUETIAPINE XR | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-04-03 | 2018-02-21 | 5223 |
ACT OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-05-24 | 2017-09-19 | 10978 |
TEVA-METHYLPHENIDATE ER-C | 18MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2017-11-24 | 2020-01-21 | 30668 |
TEVA-METHYLPHENIDATE ER-C | 27MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2017-11-24 | 2020-01-21 | 30685 |
TEVA-METHYLPHENIDATE ER-C | 36MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2017-11-24 | 2020-01-21 | 30688 |
TEVA-METHYLPHENIDATE ER-C | 54MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2017-11-24 | 2020-01-21 | 30691 |
TEVA-QUETIAPINE XR | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-03-16 | 2018-05-30 | 43168 |
TEVA-DICLOFENAC SR | 75MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2018-10-23 | 2020-02-13 | 65490 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
ACT OXYCODONE CR | 5MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65328 |
ACT DONEPEZIL ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64872 |
ACT DONEPEZIL ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64875 |
ACT OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2019-10-25 | 2019-10-26 | 97256 |
ACT OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-01-24 | 2020-01-24 | 104277 |
TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-25 | 2019-10-26 | 97248 |
TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-31 | 2019-11-01 | 97589 |
TEVA-DEFERASIROX | 125MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103791 |
TEVA-DEFERASIROX | 250MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103796 |